CME Group (CME) Stock Forecast & Price Target $291.23 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$290.60 -0.63 (-0.22%) As of 05/22/2026 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CME Group - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 18 Analyst RatingsSell2Hold6Buy10 Based on 18 Wall Street analysts who have issued ratings for CME Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 2 have given a sell rating, 6 have given a hold rating, 8 have given a buy rating, and 2 have given a strong buy rating for CME. Consensus Price Target $305.294.83% Upside According to the 18 analysts' twelve-month price targets for CME Group, the average price target is $305.29. The highest price target for CME is $353.00, while the lowest price target for CME is $209.00. The average price target represents a forecasted upside of 4.83% from the current price of $291.23. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for CME and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CME Group and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CME Analyst Ratings Over TimeTypeCurrent Forecast5/25/25 to 5/25/261 Month Ago4/25/25 to 4/25/263 Months Ago2/24/25 to 2/24/261 Year Ago5/25/24 to 5/25/25Strong Buy2 Strong Buy rating(s)2 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy8 Buy rating(s)8 Buy rating(s)9 Buy rating(s)5 Buy rating(s)Hold6 Hold rating(s)6 Hold rating(s)6 Hold rating(s)8 Hold rating(s)Sell2 Sell rating(s)2 Sell rating(s)3 Sell rating(s)3 Sell rating(s)Consensus Price Target$305.29$306.71$299.53$256.80Forecasted Upside4.83% Upside7.61% Upside-6.11% Downside-9.60% DownsideConsensus RatingModerate BuyModerate BuyHoldHold CME Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CME Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CME Group Stock vs. The CompetitionTypeCME GroupFinance CompaniesBroader MarketConsensus Rating Score 2.56 2.31 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside4.83% Upside27.42% Upside15.09% UpsideNews Sentiment RatingPositive NewsSee Recent CME NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails4/27/2026 Rothschild & Co Redburn4 of 5 stars Lower TargetNeutral$340.00 ➝ $316.00+11.02%4/23/2026 Barclays3 of 5 starsBenjamin Budish3 of 5 starsLower TargetEqual Weight$343.00 ➝ $316.00+10.60%4/23/2026 Deutsche Bank Aktiengesellschaft2 of 5 stars Lower TargetBuy$342.00 ➝ $322.00+14.77%4/23/2026 TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetBuy$340.00 ➝ $323.00+13.74%4/23/2026 Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMichael CyprysSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$362.00 ➝ $353.00+24.30%4/23/2026 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetSell$275.00 ➝ $267.00-5.85%4/16/2026 JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetUnderweight$266.00 ➝ $271.00-8.75%4/15/2026 Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick MoleySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$313.00 ➝ $329.00+10.98%4/9/2026 Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetBuy$356.00 ➝ $349.00+16.34%4/8/2026 Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingChris AllenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingInitiated CoverageMarket Perform$305.00-1.80% Get the Latest News and Ratings for CME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. 4/6/2026 Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetOutperform$310.00 ➝ $320.00+4.64%3/5/2026 Erste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeHold ➝ Strong-Buy3/4/2026 ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingStephen BiggarSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingBuy ➝ Hold3/2/2026 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeBuy (B+) ➝ Buy (A-)2/6/2026 UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAlex KrammSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingNeutral$310.00+4.24%2/5/2026 Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAshish SabadraSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetSector Perform$295.00 ➝ $302.00+2.50%12/10/2025 Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost Target$201.00 ➝ $209.00-21.53%9/25/2025 CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingChristopher AllenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeNeutral ➝ Buy$275.00 ➝ $300.00+13.45%7/24/2025 OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingOwen LauSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$300.00 ➝ $303.00+9.30%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:38 AM ET. Should I Buy CME Group Stock? CME Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 20, 2026. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com. CME Group Bull Case Here are some ways that investors could benefit from investing in CME Group Inc.: The current stock price is around $297.70, which may present a buying opportunity for investors looking to enter at a favorable level. CME Group Inc. operates some of the largest and most liquid derivatives exchanges globally, providing a strong competitive advantage in the financial markets. Recent analyst commentary has been moderately constructive, indicating positive sentiment towards the company's future performance. The company has a solid market capitalization of approximately $107.87 billion, reflecting its stability and growth potential in the financial sector. Insider activity shows that corporate insiders have been selling shares, which can sometimes indicate confidence in the company's future performance, as they may be reallocating their investments. CME Group Bear Case Investors should be bearish about investing in CME Group Inc. for these reasons: There is ongoing lobbying by CME Group Inc. and competitors to increase regulatory scrutiny on unregulated platforms, which could indicate potential challenges in maintaining market share. Recent insider sales, while sometimes seen as a positive sign, could also raise concerns about the confidence of executives in the company's short-term performance. The price-to-earnings ratio of 25.40 suggests that the stock may be overvalued compared to its earnings, which could deter value-focused investors. The company has a relatively low insider ownership of 0.30%, which may indicate a lack of alignment between management and shareholder interests. Market conditions and macroeconomic factors, such as potential interest rate hikes indicated by CME's FedWatch tool, could negatively impact trading volumes and profitability. CME Forecast - Frequently Asked Questions What is CME Group's forecast for 2026? According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for CME Group is $305.29, with a high forecast of $353.00 and a low forecast of $209.00. Should I buy or sell CME Group stock right now? 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 6 hold ratings, 8 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CME shares. Does CME Group's stock price have much upside? According to analysts, CME Group's stock has a predicted upside of 4.83% based on their 12-month stock forecasts. Has CME Group been upgraded by Wall Street analysts recently? Over the previous 90 days, CME Group's stock had 2 upgrades by analysts. What analysts cover CME Group? CME Group has been rated by research analysts at Argus, Barclays, Deutsche Bank Aktiengesellschaft, Erste Group Bank, Jefferies Financial Group, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, Raymond James Financial, Rothschild & Co Redburn, TD Cowen, The Goldman Sachs Group, and Weiss Ratings in the past 90 days. Do Wall Street analysts like CME Group more than its competitors? Analysts like CME Group more than other "finance" companies. The consensus rating for CME Group is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how CME compares to other companies. Stock Forecasts and Research Tools Related Companies Cboe Global Markets Stock Forecast Coinbase Global Stock Forecast MarketAxess Stock Forecast Nasdaq Stock Forecast NVIDIA Stock Forecast Interactive Brokers Group Stock Forecast Intercontinental Exchange Stock Forecast Moody's Stock Forecast MSCI Stock Forecast Arrow Financial Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With CME Group RecommendationsRothschild & Co RedburnWall Street ZenBarclaysMorgan StanleyThe Goldman Sachs GroupTD CowenDeutsche Bank AktiengesellschaftJPMorgan Chase & Co.Piper SandlerJefferies Financial GroupKeefe, Bruyette & WoodsRaymond James FinancialErste Group BankArgusWeiss Ratings This page (NASDAQ:CME) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s $1 Quadrillion AI IPO$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CME Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
